Stock screenerAll disclosures →
EDGAR →
STRO
Conviction 51HealthcareScan · Mon, Aug 10, 2026STRO$25.52+0.55%
ResistanceSupportVol 14Vol MA14 255.51K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price25.52
Change+0.55%
Gap+2.17%
Rel volume3.33×
Avg volume282.26K
Avg $ vol6.85M
SMA 2024.29
SMA 5027.18
SMA 20019.95
Price vs 50-6.10%
Price vs 200+27.95%
MA stackmixed
50/200 cross—
Supertrenddown · 29.03
RSI (14)49
MACD hist0.36
MACD crossbull · 6d
Stoch %K / %D81 / 71
ADX (14)18
+DI / −DI16 / 21
RSI divergence—
MACD divergence—
ATR %+7.46%
ADR %6.69%
52w high40.91
52w low0.7298
From 52w high-37.62%
Above 52w low+3396.85%
New 52w highNo
SqueezeOff
Bollinger width17.33%
%B0.79
Donchian pos59.19%
Donchian high28.14
Donchian low21.72
AVWAP (52w high)28.53
vs AVWAP high-10.54%
AVWAP (52w low)24.71
vs AVWAP low+3.28%
OBV trendFlat
Chaikin MF (20)-0.12
Today vs 20d3.33×
Avg vol (14d)255.5K
Avg vol (20d)282.26K
Avg $ vol (20d)6.85M
Market cap—
RS 3m (vs SPY)-41.98%
RS 6m (vs SPY)+59.72%
RS line new highNo
Trend template5/8
Technical rank65.5
1 week+1.67%
1 month-14.16%
3 months-36.58%
6 months+64.43%
1 year+3090.00%
YTD+132.85%
P/E-2.19
P/B-6.26
P/S4.08
P/FCF-2.34
EPS-22.49
Div yield—
ROE285.68%
ROA-78.97%
Debt/Eq-0.06
Current3.12
EV/EBITDA-2.31
Gross margin—
Net margin-186.45%
Rev growth65.18%
EPS growth15.99%
Price target51.83
Target upside105.27%
Analyst ratingBuy
Institutional97.15%
Ent. value348.78M
Revenue14.52M
Net income-38.48M
Gross profit—
Free cash flow-178.79M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out16.57M
Employees133
ListedThu, Sep 27, 2018
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction51 / 100
Pattern quality—
Tech rank65.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance33.70
Support21.99
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in STRO
No recent disclosed trades by Congress in STRO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in STRO · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hunter Heidi Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Petree Daniel H Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
MATSUI CONNIE Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Jagpal Sukhi Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
PANEK JAMES P Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Wigginton Jon Marc Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Dybbs Michael Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Lobacki Joseph M Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Chow Gregory K. CFO · Restricted Stock Units (RSUs) · 2026-06-02 | Exercise | 2.5K | $0 | 2026-06-02 | 2026-06-02 |
Chow Gregory K. CFO · Common Stock · 2026-06-02 | Exercise | 2.5K | $0 | 2026-06-02 | 2026-06-02 |
SEC filings
EDGAR filings in STRO · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.